COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,735 Articles (22,502 medRxiv, 8,233 bioRxiv)

Most recent first Previous |  Page 1191: Articles 11901-11910  | Next

Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19
Piras, I. S., Huentelman, M., Walker, J., Arche, R., Glass, M., Vargas, D., Sue, L., Intorcia, A., Nelson, C., Suszczewicz, K., Borja, C., Desforges, M., Deture, M., Dicksond, D., Beach, T., Serrano, G.
10.1101/2021.09.12.21263291 — Posted: 2021-09-15
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Liu, Y., Zeng, Q., Deng, C., Li, M., Li, L., Liu, D., Mei, J., Mo, R., Zhou, Q., Liu, M., Peng, S., Wang, J., Zhang, H., Xiao, H.
10.1101/2021.09.12.21263373 — Posted: 2021-09-15
A comparative study of Bacterial culture isolates, site of infections and drug resistance pattern between COVID and non COVID patients admitted in a tertiary care hospital : A Pilot study
Haldar, A. K., Mukherjee, D. N., Seal, S., Dasgupta, H., Chakraborty, M.
10.1101/2021.09.12.21263386 — Posted: 2021-09-15
Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications in Australia
Enticott, J., Gill, J., Bacon, S., Lavoie, K. L., Epstein, D., Dawadi, S., Teede, H., Boyle, J.
10.1101/2021.09.12.21263158 — Posted: 2021-09-15
'Like brushing teeth' - Implementation experiences with opt-in, at-home screening for SARS-CoV-2 among schoolchildren in Germany
Wachinger, J., Schirmer, M., Taeuber, N., McMahon, S. A., Denkinger, C. M.
10.1101/2021.09.13.21263486 — Posted: 2021-09-15
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccine in Children and Adolescents: A Systematic Review
Lv, M., Luo, X., Shen, Q., Lei, R., Liu, X., Liu, E., Li, Q., Chen, Y.
10.1101/2021.09.11.21262855 — Posted: 2021-09-15
Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators.
Rodriguez-Marrtino, E., Medina-Prieto, R., Santana-Bagur, J., Sante, M., Pantoja, P., Espino, A. M., Sariol, C. A., Torres, E. A.
10.1101/2021.09.11.21263211 — Posted: 2021-09-15
What pushed Israel out of herd immunity? Modeling COVID-19 spread of Delta and Waning immunity
De-Leon, H., Aran, D.
10.1101/2021.09.12.21263451 — Posted: 2021-09-15
Scale-free dynamics of Covid-19 in a Brazilian city
Policarpo, J. M. P., Ramos, A. A. G. F., Dye, C., Faria, N. R., Leal, F. E., Moraes, O. J. S., Parag, K. V., Peixoto, P. S., Sabino, E. C., Nascimento, V. H., Deppman, A.
10.1101/2021.09.10.21263332 — Posted: 2021-09-15
Effectiveness of Mass Vaccination in Brazil against Severe COVID-19 Cases
Villela, D. A. M., de Noronha, T. G., Bastos, L. S., Pacheco, A. G. F., Cruz, O. G., Carvalho, L. M., Codeco, C. T., Gomes, M. F. C., Coelho, F. C., Freitas, L. P., Lana, R. M., Porto, V. B. G., Camacho, L. A., Struchiner, C. J.
10.1101/2021.09.10.21263084 — Posted: 2021-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).